Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer

by Tomas Tesar, Laszlo Szilberhorn, Laszlo Szilberhorn, Bertalan Nemeth, Balazs Nagy, Balazs Nagy, Martin Wawruch, Zoltan Kalo, Zoltan Kalo
Published 2017-12-01

Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Cr...

by Ivett Jakab, Bertalan Németh, Baher Elezbawy, Melis Almula Karadayı, Hakan Tozan, Sabahattin Aydın, Jie Shen, Zoltán Kaló, Zoltán Kaló
Published 2020-08-01

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia

by Andras Inotai, Diana Brixner, Nikos Maniadakis, Iwan Dwiprahasto, Erna Kristin, Agus Prabowo, Alfi Yasmina, Sigit Priohutomo, Bertalan Németh, Kalman Wijaya, Zoltan Kalo
Published 2018-12-01

Using informative prior based on expert opinion in Bayesian estimation of the transition probability matrix in Markov modelling—an example from the cost-effectiveness analysis of t...

by Zoltán Vokó, István Bitter, Beatrix Mersich, János Réthelyi, Anett Molnár, János G. Pitter, Árpád Götze, Margit Horváth, Kristóf Kóczián, Laura Fonticoli, Filippo Lelli, Bertalan Németh
Published 2020-08-01